Suven Pharmaceuticals Limited

NSEI:SUVENPHAR Stock Report

Market Cap: ₹170.5b

Suven Pharmaceuticals Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Sudhir Singh

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenureless than a year

Recent management updates

Recent updates

These 4 Measures Indicate That Suven Pharmaceuticals (NSE:SUVENPHAR) Is Using Debt Safely

Dec 15
These 4 Measures Indicate That Suven Pharmaceuticals (NSE:SUVENPHAR) Is Using Debt Safely

Robust Earnings May Not Tell The Whole Story For Suven Pharmaceuticals (NSE:SUVENPHAR)

Aug 03
Robust Earnings May Not Tell The Whole Story For Suven Pharmaceuticals (NSE:SUVENPHAR)

Does Suven Pharmaceuticals (NSE:SUVENPHAR) Have A Healthy Balance Sheet?

May 12
Does Suven Pharmaceuticals (NSE:SUVENPHAR) Have A Healthy Balance Sheet?

Suven Pharmaceuticals Limited (NSE:SUVENPHAR) Investors Are Less Pessimistic Than Expected

Mar 26
Suven Pharmaceuticals Limited (NSE:SUVENPHAR) Investors Are Less Pessimistic Than Expected

Here's Why We Think Suven Pharmaceuticals (NSE:SUVENPHAR) Is Well Worth Watching

Mar 07
Here's Why We Think Suven Pharmaceuticals (NSE:SUVENPHAR) Is Well Worth Watching

These 4 Measures Indicate That Suven Pharmaceuticals (NSE:SUVENPHAR) Is Using Debt Safely

Nov 30
These 4 Measures Indicate That Suven Pharmaceuticals (NSE:SUVENPHAR) Is Using Debt Safely

Do Suven Pharmaceuticals's (NSE:SUVENPHAR) Earnings Warrant Your Attention?

Sep 03
Do Suven Pharmaceuticals's (NSE:SUVENPHAR) Earnings Warrant Your Attention?

Here's Why Suven Pharmaceuticals (NSE:SUVENPHAR) Can Manage Its Debt Responsibly

Aug 04
Here's Why Suven Pharmaceuticals (NSE:SUVENPHAR) Can Manage Its Debt Responsibly

Analysts Have Made A Financial Statement On Suven Pharmaceuticals Limited's (NSE:SUVENPHAR) Full-Year Report

Jun 11
Analysts Have Made A Financial Statement On Suven Pharmaceuticals Limited's (NSE:SUVENPHAR) Full-Year Report

With EPS Growth And More, Suven Pharmaceuticals (NSE:SUVENPHAR) Is Interesting

Apr 13
With EPS Growth And More, Suven Pharmaceuticals (NSE:SUVENPHAR) Is Interesting

Does Suven Pharmaceuticals (NSE:SUVENPHAR) Have A Healthy Balance Sheet?

Mar 08
Does Suven Pharmaceuticals (NSE:SUVENPHAR) Have A Healthy Balance Sheet?

Can Suven Pharmaceuticals Limited's (NSE:SUVENPHAR) ROE Continue To Surpass The Industry Average?

Feb 08
Can Suven Pharmaceuticals Limited's (NSE:SUVENPHAR) ROE Continue To Surpass The Industry Average?

CEO

Sudhir Singh (58 yo)

less than a year

Tenure

Dr. Sudhir Kumar Singh, Ph.D. serves as Chief Executive Officer since September 29, 2023 at Suven Pharmaceuticals Ltd. He served as Chief Operating Officer of Aragen Life Sciences Private Limited from Sept...


Leadership Team

NamePositionTenureCompensationOwnership
Vaidheesh Annaswamy
Executive Chairmanless than a yearno datano data
Sudhir Singh
Chief Executive Officerless than a yearno datano data
Himanshu Agarwal
Chief Financial Officerless than a yearno datano data
K. Babu
Chief Quality & Compliance Officerno datano datano data
Gaurav Bahadur
Chief Human Resources Officerless than a yearno datano data
Vetukuri Venkata Naga Kali Vara Raju
MD & Directorno datano datano data
Subba Komaravolu
Chief Strategy Officerless than a yearno datano data
Brian Shaughnessy
Chief Commercial Officerless than a yearno datano data
K. Rao
Company Secretaryno datano datano data
Sunder Venkatraman
Vice President of Corporate Affairs3.3yrsno datano data

0.7yrs

Average Tenure

55.5yo

Average Age

Experienced Management: SUVENPHAR's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Vaidheesh Annaswamy
Executive Chairmanless than a yearno datano data
Vetukuri Venkata Naga Kali Vara Raju
MD & Directorless than a yearno datano data
Abhijit Mukherjee
Member of Advisory Councilless than a yearno datano data
Venkateswarlu Jasti
Member of Advisory Councilless than a year₹98.16m0.00079%
₹ 1.3m
Shweta Jalan
Non-Executive Directorless than a yearno datano data
Pankaj Patwari
Non-Executive Directorless than a yearno datano data
Vinod Rao
Independent Directorless than a yearno datano data
Matangi Gowrishankar
Independent Directorless than a yearno datano data
Stefan Stoffel
Member of Advisory Councilless than a yearno datano data
Pravin Udhyavara Rao
Independent Directorless than a yearno datano data
Kumarapuram Ananthakrishnan
Independent Directorless than a yearno datano data

0.7yrs

Average Tenure

62yo

Average Age

Experienced Board: SUVENPHAR's board of directors are not considered experienced ( 0.7 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.